Jiangsu Nhwa Pharmaceutical Hits Day Low Amid Price Pressure at CNY 25.35

Jiangsu Nhwa Pharmaceutical Co., Ltd. experienced a significant decline in its stock price today, dropping by 6.42% as of October 14, 2025. The stock reached an intraday low of CNY 25.35, reflecting a challenging day for the company in the pharmaceuticals and biotechnology sector.
In comparison to the broader market, Jiangsu Nhwa's performance has lagged behind the China Shanghai Composite, which saw a modest decline of 0.19% on the same day. Over the past week, the stock has decreased by 6.18%, and its one-month performance shows a decline of 5.48%. Year-to-date, the stock remains positive with a gain of 4.8%, although it has underperformed over the past year with a return of -5.27%.

Financial metrics indicate that Jiangsu Nhwa maintains a return on equity of 15.83% and a price-to-earnings ratio of 20.00. The company also boasts a dividend yield of 1.32%, which may appeal to income-focused investors. Despite today's downturn, the stock's long-term performance over three, five, and ten years shows substantial growth compared to the market.